Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Shares, $0.001 par value
-
Shares outstanding
-
15.4M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
4.56M
-
Shares change
-
-311K
-
Total reported value, excl. options
-
$60.2M
-
Value change
-
-$4.11M
-
Number of buys
-
22
-
Number of sells
-
-21
-
Price
-
$13.21
Significant Holders of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) as of Q3 2021
57 filings reported holding GRX - Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value as of Q3 2021.
Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.56M shares
of 15.4M outstanding shares and own 29.52% of the company stock.
Largest 10 shareholders include WELLS FARGO & COMPANY/MN (613K shares), Karpus Management, Inc. (474K shares), MORGAN STANLEY (473K shares), LAZARD ASSET MANAGEMENT LLC (467K shares), GAMCO INVESTORS, INC. ET AL (319K shares), ROYAL BANK OF CANADA (255K shares), Cornerstone Advisors, LLC (212K shares), UBS Group AG (210K shares), Matisse Capital (196K shares), and BENNICAS & ASSOCIATES, INC. (167K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.